Hanmi Pharmaceutical Company Limited

This study tests a new medicine called HM15275 for people with type 2 diabetes. About 180 adults who manage their diabetes with diet and exercise or metformin will receive either the drug or a placebo for 36 weeks. The main goal is to see if the drug improves blood sugar control,…

This study compares two similar oral drugs in 60 healthy adults aged 19-64. The goal is to see how the body processes each drug and to check for safety. Participants will take a single dose of each drug at different times. This is a Phase 1 trial with no direct treatment benefit.